Shopping Cart
- Remove All
- Your shopping cart is currently empty
INX-315, an orally active and selective CDK2 inhibitor, induces cell cycle arrest in the G1 phase, reduces CDK2 substrate phosphorylation, and inhibits tumor growth dose-dependently in xenograft mouse models. INX-315 may be used in cancer research [1].
Pack Size | Price | Availability | Quantity |
---|---|---|---|
10 mg | Inquiry | 10-14 weeks | |
50 mg | Inquiry | 10-14 weeks |
Description | INX-315, an orally active and selective CDK2 inhibitor, induces cell cycle arrest in the G1 phase, reduces CDK2 substrate phosphorylation, and inhibits tumor growth dose-dependently in xenograft mouse models. INX-315 may be used in cancer research [1]. |
Molecular Weight | 427.48 |
Formula | C19H21N7O3S |
Cas No. | 2745060-92-6 |
Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.